Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.
Background Bisphosphonates are powerful drugs used for the management of osteoporosis and metastatic bone disease to avoid skeletal-related complications. Side effects are rare but potentially serious such as the bisphosphonate-related osteonecrosis of the jaws (BRONJ). BRONJ impairs the quality of life and can even lead to pathologic fractures of the mandible. Management of BRONJ is difficult per se. If complicated with pathologic mandibular fractures in advanced stages, the treatment options are controversially discussed. This review delineates the epidemiology and pathogenesis of BRONJ to put the various modalities for the treatment of pathologic mandible fractures into perspective. Methods Various case reports and case series in the literature were reviewed. Cases were reviewed of patients suffering from pathologic fracture due to bisphosphonate-related osteonecrosis of the jaw treated in the Department of Oral and Maxillofacial Surgery (Ludwig-Maximilians-University of Munich) from 2003 to 2010. Of 140 patients suffering from BRONJ, four were identified with pathologic fracture of the mandible. Results Management of pathologic mandibular fractures in patients suffering from BRONJ is an unsolved issue. At present there is a paucity of information to establish reliable therapy guidelines. The published strategies range from conservative treatment to major bone resections with or without internal or external fixation and with or without autogenous reconstruction. There is no evidence for the superiority of a single therapeutic mode, however. Conclusion Further understanding of BRONJ is mandatory to establish a sound rationale for the treatment of associated mandibular fractures.
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Sven
S
Otto
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Christoph
C
Pautke
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Sigurd
S
Hafner
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Ronny
R
Hesse
Department of Oral and Maxillofacial Surgery, University of Leipzig, Germany.
Lea Franziska
LF
Reichardt
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Gerson
G
Mast
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Michael
M
Ehrenfeld
Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University, Munich, Germany.
Carl-Peter
CP
Cornelius
bisphosphonates BRONJ; osteonecrosis of the jaw; pathologic fractures